Louisiana Medical Mutual Insurance Company (LAMMICO)

TOLAC Risk Issues

TOLAC is defined as a trial of labor after one or more cesarean deliveries intended to result in a vaginal birth instead of a scheduled repeat Cesarean Section. Successful vaginal birth after Cesarean (VBAC) rates in TOLAC patients are reported…

Labor Induction-Module 7: Oxytocin Safe Administration

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Labor Induction-Module 6: Oxytocin Pharmacodynamics

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Labor Induction-Module 5: Misoprostol

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Labor Induction-Module 4: Mechanical Methods

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Labor Induction-Module 3: Cervical Ripening

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Labor Induction-Module 2: Indications, Contraindications, ARRIVE Trial

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Labor Induction-Module 1: Verdicts, Settlements, and a Case Study

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Emergency Medicine: Risk and Claims, Part 2

More than 60,500 active emergency physicians in the U.S. operate under time pressure within a high risk, high volume and often under resourced environment. They most often see a patient only once, usually in a situation in which the patient…

Emergency Medicine: Risk and Claims, Part 1

More than 60,500 active emergency physicians in the U.S. operate under time pressure within a high risk, high volume and often under resourced environment. They most often see a patient only once, usually in a situation in which the patient…